Insulin Aspart
11 NDCs across 1 manufacturer|5 Generic,6 Brand
▸ More about this market▾ Less
In 2024, Medicare Part D spent $463 million on Insulin Aspart across 2.2 million claims for 750,000 beneficiaries.
Insulin Aspart is available as 11 NDCs from 1 manufacturer (5 generic, 6 brand), with NADAC prices from $6.93 to $8.96 per ML — a 29% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
11
5G / 6B
Manufacturers
1
competing in market
Price Spread
$6.93 – $8.96
per ML
7d Activity
avg -0.0% WoW · of 11 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Novo Nordisk manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Insulin Analog class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing INSULIN ASPART
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
INSULIN ASPART FLEXPEN 100 UNIT/ML PEN | $8.9607 per ML | — |
NOVOLOG MIX 70-30 FLEXPEN | $8.9370 per ML | -0.02% |
NOVOLOG 100 UNIT/ML FLEXPEN | $8.9351 per ML | -0.01% |
INSULIN ASPART PROTAMINE-INSULIN ASPART MIX 70-30 FLEXPEN | $8.9345 per ML | — |
INSULIN ASPART PENFILL 100 UNIT/ML CARTRIDGE | $8.5706 per ML | — |
NOVOLOG PENFILL 100 UNIT/ML | $8.5693 per ML | -0.05% |
FIASP PUMPCART 100 UNIT/ML | $8.5686 per ML | -0.05% |
INSULIN ASPART 100 UNIT/ML VL | $6.9548 per ML | — |
INSULIN ASPART PROTAMINE-INSULIN ASPART MIX 70-30 VIAL | $6.9545 per ML | — |
NOVOLOG 100 UNIT/ML VIAL | $6.9352 per ML | -0.01% |
NOVOLOG MIX 70-30 VIAL | $6.9287 per ML | +0.01% |
Frequently Asked Questions
How much does Medicare spend on Insulin Aspart?
In 2024, Medicare Part D spent $463 million on Insulin Aspart across 2.2 million claims for 750,000 beneficiaries.
How many Insulin Aspart products are on the market?
The Insulin Aspart drug market contains 11 NDCs from 1 manufacturer — 5 generic and 6 brand products.
What is the price range for Insulin Aspart?
NADAC reference prices for Insulin Aspart range from $6.9287 to $8.9607 per ML — a 29% difference between cheapest and most expensive.
Is generic Insulin Aspart cheaper than brand?
The average generic NADAC for Insulin Aspart is $8.0750 per ML, versus $8.1457 for brand-labeled products — generic is about 1% cheaper on average.
Which manufacturers make Insulin Aspart?
1 manufacturer lists Insulin Aspart in NADAC. Ranked by number of NDCs, the largest are Novo Nordisk (11).
How has the price of Insulin Aspart changed recently?
Over the past 7 days, 1 Insulin Aspart NDC rose and 5 fell, with a market-wide average change of -0.0%.